Supporting smoking cessation

Nicholas A. Zwar*, Colin P. Mendelsohn, Robyn L. Richmond

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

35 Citations (Scopus)

Abstract

Summary points
- Throughout the world tobacco smoking is the leading cause of preventable death and illness
- As smoking rates in the general population fall in developed countries, a greater proportion of smokers have coexisting problems such as mental illness
- Cessation support from doctors and other health professionals increases quit rates
- Tobacco dependence is most effectively treated with a comprehensive approach involving behavioural support and pharmacotherapy
- Effective medicines include nicotine replacement therapy, varenicline, bupropion, nortriptyline, and cytisine. The availability and registration of these medicines varies between countries
Original languageEnglish
Article numberf7535
JournalBMJ (Online)
Volume348
DOIs
Publication statusPublished - 14 Jan 2014
Externally publishedYes

Fingerprint Dive into the research topics of 'Supporting smoking cessation'. Together they form a unique fingerprint.

  • Cite this

    Zwar, N. A., Mendelsohn, C. P., & Richmond, R. L. (2014). Supporting smoking cessation. BMJ (Online), 348, [f7535]. https://doi.org/10.1136/bmj.f7535